Takahiro Soda, M.D., Ph.D.
Assistant Professor
About Takahiro Soda
Dr. Soda is board certified in general psychiatry and child and adolescent psychiatry. He obtained his medical degree from Harvard Medical School and obtained his PhD from the Massachusetts Institute of Technology in Cambridge, Massachusetts as part of the Harvard-MIT Division of Health Sciences and Technology Medical Scientist Training Program.
Dr. Soda completed his residency in general psychiatry and a fellowship in child and adolescent psychiatry at the University of North Carolina Hospitals. He is a member of AACAP ethics committee and ISPG ethics committee.
Dr. Soda works in the Child Division and provides patient care services at the UF Health Springhill II clinic and UF Health Shands Psychiatric Hospital. He also conducts clinical research in autism and neurodevelopmental disorders in adults, adolescents, and children. He has an integral role in the development of research programs in both the UF Health Center for Autism and Neurodevelopment (CAN), and in the UF Center for OCD, Anxiety and Related Disorders (COARD). In addition, he serves as an important academic teacher and mentor for medical students, interns, training residents and fellows.
Additional Positions:
Medical Director
2020 – Current
·
UF Health Center for Autism and Neurodevelopment
Teaching Profile
Courses Taught
2022-2023
PAS5020 Intro to Medicine 2
Board Certifications
-
Child and Adolescent PsychiatryAmerican Board of Psychiatry and Neurology
-
PsychiatryAmerican Board of Psychiatry and Neurology
Clinical Profile
Specialties
- Psychiatry
Subspecialties
- Child and Adolescent Psychiatry
Areas of Interest
- Autism spectrum disorder
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0001-6268-2965
Areas of Interest
- Adult Psychiatry
- Autism and related disabilities
- Behavioral pharmacology
- Clinical Translational Neuroscience
- Community Psychiatry
- Neurodevelopmental Disorders
- Pediatric Psychopharmacology
- Pharmacogenetics
- Pharmacogenomics
- Psychiatric Genomics
- Psychiatry
- Psychopharmacology
- autism spectrum disorders
Publications
2023
Child and Adolescent Psychiatrists’ Use, Attitudes, and Understanding of Genetic Tests in Clinical Practice.
medRxiv : the preprint server for health sciences.
[DOI] 10.1101/2023.01.24.23284953.
[PMID] 36747629.
2023
Child and adolescent psychiatrists’ use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice
Psychiatry Research.
325
[DOI] 10.1016/j.psychres.2023.115246.
[PMID] 37172398.
2023
Editorial: Restricted repetitive behavior in neurodevelopmental disorders.
Frontiers in behavioral neuroscience.
17
[DOI] 10.3389/fnbeh.2023.1197316.
[PMID] 37143921.
2022
Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits.
The lancet. Psychiatry.
9(10):838-844
[DOI] 10.1016/S2215-0366(22)00157-2.
[PMID] 35931093.
2022
Incorporation of Telepsychiatry for Patients with Developmental Disorders into Routine Clinical Practice-A Survey of Specialty Clinics Adapting to Telepsychiatry During the COVID-19 Pandemic.
Journal of autism and developmental disorders.
52(12):5280-5284
[DOI] 10.1007/s10803-022-05593-0.
[PMID] 35575840.
2022
Psychiatric polygenic risk scores: Child and adolescent psychiatrists’ knowledge, attitudes, and experiences.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
189(7-8):293-302
[DOI] 10.1002/ajmg.b.32912.
[PMID] 35792502.
2021
A dimensional perspective on the genetics of obsessive-compulsive disorder
Translational Psychiatry.
11(1)
[DOI] 10.1038/s41398-021-01519-z.
[PMID] 34290223.
2021
Child and Adolescent Psychiatrists’ Perceptions of Utility and Self-rated Knowledge of Genetic Testing Predict Usage for Autism Spectrum Disorder
Journal of the American Academy of Child & Adolescent Psychiatry.
60(6):657-660
[DOI] 10.1016/j.jaac.2021.01.022.
[PMID] 33609654.
2021
Ethical and Clinical Considerations During the Coronavirus Era
Journal of the American Academy of Child & Adolescent Psychiatry.
60(3):332-335
[DOI] 10.1016/j.jaac.2020.12.010.
[PMID] 33338576.
2021
Systematic Quality Improvement and Metabolic Monitoring for Individuals Taking Antipsychotic Drugs.
Psychiatric services (Washington, D.C.).
72(6):647-653
[DOI] 10.1176/appi.ps.202000155.
[PMID] 33887956.
2020
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic).
European archives of psychiatry and clinical neuroscience.
270(7):921-932
[DOI] 10.1007/s00406-019-01087-w.
[PMID] 31802253.
2020
Sex differences associated with corpus callosum development in human infants: A longitudinal multimodal imaging study.
NeuroImage.
215
[DOI] 10.1016/j.neuroimage.2020.116821.
[PMID] 32276067.
2019
International Society of Psychiatric Genetics Ethics Committee: Issues facing us.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
180(8):543-554
[DOI] 10.1002/ajmg.b.32736.
[PMID] 31124312.
2019
LEGAL AND ETHICAL IMPLICATIONS OF CRISPR APPLICATIONS IN PSYCHIATRY.
North Carolina law review.
97(5):1359-1398
[PMID] 31871365.
2019
The Genomics of Electroconvulsive Therapy International Consortium (GenECT-ic).
The lancet. Psychiatry.
6(10)
[DOI] 10.1016/S2215-0366(19)30343-8.
[PMID] 31544767.
2017
A search for the common ground between Tic; Obsessive-compulsive and Autism Spectrum Disorders: part I, Tic disorders.
AIMS genetics.
4(1):32-46
[DOI] 10.3934/genet.2017.1.32.
[PMID] 31435502.
2015
Altered corpus callosum morphology associated with autism over the first 2 years of life.
Brain : a journal of neurology.
138(Pt 7):2046-58
[DOI] 10.1093/brain/awv118.
[PMID] 25937563.
2013
DISC1-ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by DISC1.
Molecular psychiatry.
18(8):898-908
[DOI] 10.1038/mp.2013.38.
[PMID] 23587879.
2012
Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex.
Nature neuroscience.
15(7):1022-31
[DOI] 10.1038/nn.3141.
[PMID] 22683681.
2011
Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1).
The Journal of neuroscience : the official journal of the Society for Neuroscience.
31(44):15751-6
[DOI] 10.1523/JNEUROSCI.3588-11.2011.
[PMID] 22049418.
2009
Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling.
Cell.
136(6):1017-31
[DOI] 10.1016/j.cell.2008.12.044.
[PMID] 19303846.
2004
Increased GABAergic function in mouse models of Huntington’s disease: reversal by BDNF.
Journal of neuroscience research.
78(6):855-67
[PMID] 15505789.
Grants
Jan 2022
– Mar 2024
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders
Role: Co-Investigator
Funding: GEISINGER MEDICAL CENTER
via NATL INST OF HLTH NIMH
Sep 2021
ACTIVE
Polygenic Risk Scores in Child and Adolescent Psychiatry: Ethical, Clinical, and Legal Implications
Role: Principal Investigator
Funding: BAYLOR COLLEGE OF MEDICINE
via NATL INST OF HLTH NIMH
Education
Fellowship in Child and Adolescent Psychiatry
2019
·
University of North Carolina Hospitals
Residency in General Psychiatry
2018
·
University of North Carolina Hospitals
Ph. D in Neuroscience
2007-2012
·
Massachusetts Institute of Technology
Medical Degree
2005-2014
·
Harvard Medical School
Bachelor's of Science in Neuroscience
2001-2005
·
University of California – Los Angeles
Contact Details
Phones:
- Business:
- (352) 294-4946
Emails:
- Business:
- takahirosoda@ufl.edu
Addresses:
- Business Mailing:
-
1149 NEWELL DR
GAINESVILLE FL 32610 - Business Street:
-
1149 NEWELL DR
GAINESVILLE FL 32610